Focal Epilepsy Resulting from a de novo SCN1A Mutation

Abstract

We found a de novo missense mutation of the gene encoding the α1 subunit of the neuro-nal voltage-gated sodium channel, SCN1A, in a patient with repetitive focal seizures. At 5 months of age, the patient had a first seizure characterized by loss of consciousness and clonic convulsions in the left hand followed by secondary generalization lasting for 20 minutes in association with pyrexia. Although valproate was administered, she has had generalized seizures every month, mostly in association with elevated body temperature. Since 32 months of age, she also had a different type of seizure characterized by a fearful response followed by decreased consciousness, pallor, and salivation. Myoclonia or atypical absence seizures have never been observed until the last follow-up at 42 months of age. Genetic analysis showed a heterozygous missense mutation (c.5311A>T: I1771F) in the patient, which was not detected in her parents.

Key words

SCN1A - focal epilepsy - genotype-phenotype correlation

References

• 1 Ceulemans B, Claes LR, Lagae LG. Clinical correlations of mutations in the SCN1A gene: from febrile seizures to severe myoclonic epilepsy in infancy.  Pediatr Neurol. 2004;  30 236-243
• 2 Claes L, Del-Favero J, Ceulemans B, Lagae L, Broeckhoven C Van, Jonghe P De. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy.  Am J Hum Genet. 2001;  68 1327-1332
• 3 Escayg A, Heils A, MacDonald BT, Haug K, Sander T, Meisler MH. A novel SCN1A mutation associated with generalized epilepsy with febrile seizures plus-and prevalence of variants in patients with epilepsy.  Am J Hum Genet. 2001;  68 866-873
• 4 Fujiwara T. Clinical spectrum of mutations in SCN1A gene: severe myoclonic epilepsy in infancy and related epilepsies.  Epilepsy Res. 2006;  70S S223-S230
• 5 Fukuma G, Oguni H, Shirasaka Y, Watanabe K, Miyajima T, Yasumoto S. et al . Mutation of neuronal voltage-gated Na⁺ channel α1 subunit gene SCN1A in core severe myoclonic epilepsy in infancy (SMEI) and in borderline SMEI (SMEB).  Epilepsia. 2004;  45 140-148
• 6 Harkin LA, MacMahon JM, Iona X, Dibbens L, Pelekanos JT, Zuberi SM. et al . The spectrum of SCN1A-related infantile epileptic encephalopathies.  Brain. 2007;  130 843-852
• 7 Kanai K, Hirose S, Oguni H, Fukuma G, Shirasaka Y, Miyajima T. et al . Effect of localization of missense mutations in SCN1A on epilepsy phenotype severity.  Neurology. 2004;  63 329-334
• 8 Nabbout R, Gennaro E, Dalla Bernardina B, Dulac O, Madia F, Bertini E. et al . Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy.  Neurology. 2003;  60 1961-1967
• 9 Ohmori I, Ouchida M, Ohtsuka Y, Oka E, Shimizu K. Significant correlation of the SCN1A mutations and severe myoclonic epilepsy in infancy.  Biochem Biophys Res Commun. 2002;  295 17-23
• 10 Ohmori I, Kahlig KM, Rhodes TH, Wang DW, George  Jr  AL. Nonfunctional SCN1A is common in severe myoclonic epilepsy of infancy.  Epilepsia. 2006;  47 1636-1642
• 11 Sugawara T, Mazaki-Miyazaki E, Fukushima K, Shimomura J, Fujiwara T, Hamano S. et al . Frequent mutations of SCN1A in severe myoclonic epilepsy in infancy.  Neurology. 2002;  58 1122-1124
• 12 Wallace RH, Scheffer IE, Barnett S, Richards M, Dibbens L, Desai RR. et al . Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus.  Am J Hum Genet. 2001;  68 859-865

Correspondence